Andrzej Rostek
- Pacific Biosciences of California (PACB) will work with the n-Lorem and EspeRare Foundations to use long-read whole-genome sequencing to develop personalized antisense oligonucleotide therapies for ultra-rare genetic diseases.
- By integrating the sequencing earlier in development, “the proposed collaboration will aim to
